SIFROL ER 1.5 MG Israel - English - Ministry of Health

sifrol er 1.5 mg

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 1.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

SPIRIVA Israel - English - Ministry of Health

spiriva

boehringer ingelheim israel ltd. - tiotropium bromide - inhalation powder hard capsules - tiotropium bromide 18 mcg - tiotropium bromide - tiotropium bromide - tiotropium is a bronchodilator for the maintenance treatment of chronic obstructive pulmonary disease (copd).

VIRAMUNE TABLET 200 mg Singapore - English - HSA (Health Sciences Authority)

viramune tablet 200 mg

boehringer ingelheim singapore pte. ltd. - nevirapine - tablet - 200 mg - nevirapine 200 mg

LEVICARE HI-MINERAL New Zealand - English - Ministry for Primary Industries

levicare hi-mineral

boehringer ingelheim animal health new zealand limited - copper present as copper sulphate; selenium present as sodium selenate; potassium iodate; levamisole hydrochloride; zinc sulphate heptahydrate; cobalt sulphate heptahydrate - copper present as copper sulphate 2.63 g/litre; selenium present as sodium selenate 0.5 g/litre; potassium iodate 2.2 g/litre; levamisole hydrochloride 40 g/litre; zinc sulphate heptahydrate 3.3 g/litre; cobalt sulphate heptahydrate 1.2 g/litre - endoparasiticide

JARDIANCE DUO 12.5 MG500 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG500 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG850 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg850 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 850 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG850 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg850 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 850 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG1000 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg1000 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 1000 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 12.5 MG1000 MG Israel - English - Ministry of Health

jardiance duo 12.5 mg1000 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 1000 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.